Hematology Analyzers and Reagents Market Analysis North America, Asia, Europe, Rest of World (ROW) - US, Canada, Germany, China, Japan - Size and Forecast 2024-2028

Published: Nov 2023 Pages: 161 SKU: IRTNTR76795

Hematology Analyzers and Reagents Market Forecast 2024-2028

The Hematology Analyzers And Reagents Market size is estimated to grow by USD 3.91 billion at a CAGR of 6.95% between 2023 and 2028. 

There has been an increased adoption of hematology analyzer solutions for smaller and mid-sized laboratories over the years.  The main advantage of fully automated laboratory solutions are cost-effective and offer precise results.  In addition, automated solutions also save the time of hospitals and clinical laboratories as automation replaces manually intensive tasks, enabling researchers to focus more on analyzing and interpreting results by saving time. Furthermore, automation reduces the chances of human error, thereby improving the productivity of laboratories. Hence, such factors are positively impacting the market.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by Product, End-user, and Geography Analysis

In the field of medical diagnostics, various analyzer types are utilized to assess different parameters, often requiring specific reagents categories for accurate results. Hematology instruments play a vital role in analyzing blood samples and diagnosing hematological conditions. These instruments employ various testing methods to provide comprehensive insights into blood composition and function. With diverse application areas ranging from clinical laboratories to research facilities, hematology solutions cater to a wide range of healthcare needs. Across different industry verticals, the adoption of advanced hematology technologies enhances patient care and contributes to advancements in medical science.

Product Analysis 

The reagents and consumables segment is estimated to witness significant growth during the forecast period. The market comprises distinct product segments, which are essential for the proper functioning and performance of the hematology analyzer. Reagents refer to substances or compounds utilized in chemical reactions to identify, measure, or generate other substances whereas consumables are items that are consumed or exhausted in the analysis process and must be replaced regularly.

Get a glance at the market contribution of various segments Download PDF Sample

The reagents and consumables segment was the largest segment and was valued at USD 4.51 billion in 2018. Moreover, reagents constitute a very crucial part of the hematology system. In addition, hematology reagents are chemicals intended to perform analyses of the morphology of the blood, its components, and blood-forming tissues. Furthermore, hematology reagents are dedicated reagents used in automated cell counters. In addition, it is used to perform a quantitative and qualitative analysis of the elements of the blood. Hence, such factors are expected to fuel the growth of this segment which in turn drives the market growth during the forecast period.

End-user Analysis 

There is an extensive use of Hematology analyzers in the hospital segment such that they are indispensable diagnostic tools to diagnose and treat blood-related disorders in a timely and accurate manner. In addition, the hospital's market segment includes a broad variety of hospitals, ranging from large tertiary care institutions to community hospitals and specialized clinics. Moreover, hospitals that prioritize patient care such as large tertiary care facilities, often have a specialized hematology department that is equipped with sophisticated analyzers and a team of experts to manage many samples. In addition, to ensure rapid and reliable results, these hospitals require sophisticated, high-quality hematology analyzers that can assist in making critical decisions. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main factors that is fuelling the market growth in North America is the significant investments in healthcare research and testing in the US. For example, in 2020, according to the Centers for Medicare and Medicaid Services (CMS), US national health expenditure spending grew 2.7% to USD4.3 trillion in 2021, or USD12, 914 per person, and contributed to 18.3 % of the gross domestic product of the US In addition, factors such as the strong distribution network of market in countries such as the US and Canada and the increasing focus of manufacturers on providing a complete hematology solutions portfolio, including automated analyzers, to hospitals and diagnostic centers are fuelling the market growth in North America. Hence, such factors are driving the market growth in North America during the forecast period.

Buy Full Report Now

Key Hematology Analyzers and Reagents Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market forecasting report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories:  The company offers hematology analyzers and reagents such as CELL DYN Sapphire, CELL DYN Ruby.

  • Bio Rad Laboratories Inc.,
  • BioSystems SA,
  • Boule Diagnostics AB,
  • Danaher Corp.,
  • EKF Diagnostics Holdings Plc,
  • Erba Diagnostics FZ LLC,
  • F. Hoffmann La Roche Ltd.,
  • Heska Corp.,
  • HORIBA Ltd.,
  • Mindray Bio medical Electronics Co. Ltd.
  • NeoMedica
  • Nihon Kohden Corp.
  • Siemens AG
  • STRATEC SE
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Toyobo Co. Ltd.
  • URIT Medical Electronic Co. Ltd.
  • Zoetis Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics

In the healthcare sector, continuous technological advancements drive improvements in diagnostic tools and procedures, enhancing diagnostic accuracy and patient outcomes. Amidst evolving healthcare regulations, compliance standards ensure quality care delivery and patient safety. With an aging population and increasing disease prevalence, the demand for accurate diagnostics is more critical than ever. Streamlining laboratory processes improves laboratory efficiency, enabling timely diagnoses and treatments. Embracing cost-effective solutions addresses healthcare affordability challenges, ensuring access to quality services for all. 

Significant Trends

A key factor shaping the market growth is the increasing use of automated systems in the healthcare sector. Several market players have increased their focus on providing automated hematology analyzers and reagents for small and mid-sized laboratories, as these laboratories still rely on traditional solutions due to the high setup costs of automated hematology analyzers. For example, in 2021, Beckman Coulter Inc., a Danaher Corporation company, launched DxH 560 AL. This is an autoload hematology analyzer for small and midsized laboratories.

Moreover, the products are cost-effective and well-suited for small-sized laboratories. In addition, initially, most of the small and mid-sized laboratories relied on traditional. However, the rise in product availability specific to small and mid-sized laboratories has fuelled the adoption of hematology analyzers among them.  Hence, such factors are driving the market trends during the forecast period.

Major Challenges

Limited access in rural areas is one of the key challenges hindering the market growth. Rural areas are often characterized by a lack of healthcare services including medical facilities and qualified personnel. Therefore, it has led to a lack of availability and affordability of hematological analyzers and testing reagents, thus impeding the successful diagnosis and management of blood diseases.

Moreover, healthcare access is uneven across any country, and rural areas often lack the infrastructure and resources needed to provide quality medical care. In addition, with limited access to healthcare facilities, patients living in rural areas may not have access to hematological testing and treatments in a timely manner, including equipment and reagents needed for hematological testing. Hence, such factors are negatively impacting the market. Therefore, it is expected to hinder the market growth during the forecast period.

Buy Now Full Report

Key Customer Landscape

The market research and growth report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Market Analyst Overview

Hematology analyzers play a vital role in medical sciences by providing accurate and efficient analysis of blood components like red cells, leucocytes (white blood cells), and platelets. They measure crucial parameters like hemoglobin and hematocrit, used in complete blood count (CBC) tests, employing methods like the cyanmethemoglobin method. These analyzers come in modular structures for flexibility and some even utilize flow-cytometry techniques for advanced analysis. The global hematology analyzer market is projected to grow steadily, driven by increasing demand for point-of-care (POC) testing and advancements in technology.

However, the market faces challenges like stringent regulatory policies, the high cost of instruments, and competition from newcomers seeking market share. Despite these challenges, advancements in technology, particularly in flow-cytometry, coupled with the growing need for accurate and timely blood analysis in various settings like research institutes, blood banks, and biopharma companies, are expected to propel the market forward. As the market evolves, manufacturers will need to navigate regulations, ensure high-quality equipment, and prioritize accuracy in results to gain a competitive edge.

Segment Overview

The market growth analysis report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Product Outlook
    • Reagents and consumables
    • Instruments
  • End-user Outlook
    • Hospitals
    • Clinical laboratories
    • Research Institute
    • Others
  • Geography Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Hematology Analyzers and Reagents Market Scope

Market Report Coverage

Details

Page number

161

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.95%

Market Growth 2024-2028

USD 3.91 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

6.54

Regional analysis

North America, Asia, Europe, and the Rest of the World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Canada, Germany, China, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Bio Rad Laboratories Inc., BioSystems SA, Boule Diagnostics AB, Danaher Corp., EKF Diagnostics Holdings Plc, Erba Diagnostics FZ LLC, F. Hoffmann La Roche Ltd., Heska Corp., HORIBA Ltd., Mindray Bio medical Electronics Co. Ltd., NeoMedica, Nihon Kohden Corp., Siemens AG, STRATEC SE, Sysmex Corp., Thermo Fisher Scientific Inc., Toyobo Co. Ltd., URIT Medical Electronic Co. Ltd., and Zoetis Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market  between 2024 and 2028
  • Precise estimation of the market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Asia, Europe, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global hematology analyzers and reagents market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global hematology analyzers and reagents market 2018 - 2022 ($ million)
    • 4.2 Product Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ million)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Reagents and consumables - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2023-2028 (%)
    • 6.4 Instruments - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Instruments - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Instruments - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Instruments - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Instruments - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)
      • Exhibit 43: Data Table on Market opportunity by Product ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.4 Clinical laboratories - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%)
    • 7.5 Research institute - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Research institute - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Research institute - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Research institute - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Research institute - Year-over-year growth 2023-2028 (%)
    • 7.6 Others - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.7 Market opportunity by End-user
      • Exhibit 64: Market opportunity by End-user ($ million)
      • Exhibit 65: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.5 Europe - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 Canada - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.10 Germany - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 115: Abbott Laboratories - Overview
              • Exhibit 116: Abbott Laboratories - Business segments
              • Exhibit 117: Abbott Laboratories - Key news
              • Exhibit 118: Abbott Laboratories - Key offerings
              • Exhibit 119: Abbott Laboratories - Segment focus
            • 12.4 Bio Rad Laboratories Inc.
              • Exhibit 120: Bio Rad Laboratories Inc. - Overview
              • Exhibit 121: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 122: Bio Rad Laboratories Inc. - Key news
              • Exhibit 123: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 124: Bio Rad Laboratories Inc. - Segment focus
            • 12.5 BioSystems SA
              • Exhibit 125: BioSystems SA - Overview
              • Exhibit 126: BioSystems SA - Product / Service
              • Exhibit 127: BioSystems SA - Key offerings
            • 12.6 Boule Diagnostics AB
              • Exhibit 128: Boule Diagnostics AB - Overview
              • Exhibit 129: Boule Diagnostics AB - Product / Service
              • Exhibit 130: Boule Diagnostics AB - Key offerings
            • 12.7 Danaher Corp.
              • Exhibit 131: Danaher Corp. - Overview
              • Exhibit 132: Danaher Corp. - Business segments
              • Exhibit 133: Danaher Corp. - Key news
              • Exhibit 134: Danaher Corp. - Key offerings
              • Exhibit 135: Danaher Corp. - Segment focus
            • 12.8 EKF Diagnostics Holdings Plc
              • Exhibit 136: EKF Diagnostics Holdings Plc - Overview
              • Exhibit 137: EKF Diagnostics Holdings Plc - Business segments
              • Exhibit 138: EKF Diagnostics Holdings Plc - Key offerings
              • Exhibit 139: EKF Diagnostics Holdings Plc - Segment focus
            • 12.9 F. Hoffmann La Roche Ltd.
              • Exhibit 140: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 141: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 142: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 143: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 144: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.10 Heska Corp.
              • Exhibit 145: Heska Corp. - Overview
              • Exhibit 146: Heska Corp. - Business segments
              • Exhibit 147: Heska Corp. - Key news
              • Exhibit 148: Heska Corp. - Key offerings
              • Exhibit 149: Heska Corp. - Segment focus
            • 12.11 HORIBA Ltd.
              • Exhibit 150: HORIBA Ltd. - Overview
              • Exhibit 151: HORIBA Ltd. - Business segments
              • Exhibit 152: HORIBA Ltd. - Key offerings
              • Exhibit 153: HORIBA Ltd. - Segment focus
            • 12.12 Mindray Bio medical Electronics Co. Ltd.
              • Exhibit 154: Mindray Bio medical Electronics Co. Ltd. - Overview
              • Exhibit 155: Mindray Bio medical Electronics Co. Ltd. - Product / Service
              • Exhibit 156: Mindray Bio medical Electronics Co. Ltd. - Key offerings
            • 12.13 Nihon Kohden Corp.
              • Exhibit 157: Nihon Kohden Corp. - Overview
              • Exhibit 158: Nihon Kohden Corp. - Product / Service
              • Exhibit 159: Nihon Kohden Corp. - Key news
              • Exhibit 160: Nihon Kohden Corp. - Key offerings
            • 12.14 Siemens AG
              • Exhibit 161: Siemens AG - Overview
              • Exhibit 162: Siemens AG - Business segments
              • Exhibit 163: Siemens AG - Key news
              • Exhibit 164: Siemens AG - Key offerings
              • Exhibit 165: Siemens AG - Segment focus
            • 12.15 STRATEC SE
              • Exhibit 166: STRATEC SE - Overview
              • Exhibit 167: STRATEC SE - Business segments
              • Exhibit 168: STRATEC SE - Key offerings
              • Exhibit 169: STRATEC SE - Segment focus
            • 12.16 Sysmex Corp.
              • Exhibit 170: Sysmex Corp. - Overview
              • Exhibit 171: Sysmex Corp. - Business segments
              • Exhibit 172: Sysmex Corp. - Key offerings
              • Exhibit 173: Sysmex Corp. - Segment focus
            • 12.17 Zoetis Inc.
              • Exhibit 174: Zoetis Inc. - Overview
              • Exhibit 175: Zoetis Inc. - Business segments
              • Exhibit 176: Zoetis Inc. - Key news
              • Exhibit 177: Zoetis Inc. - Key offerings
              • Exhibit 178: Zoetis Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 179: Inclusions checklist
                • Exhibit 180: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 181: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 182: Research methodology
                • Exhibit 183: Validation techniques employed for market sizing
                • Exhibit 184: Information sources
              • 13.5 List of abbreviations
                • Exhibit 185: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              hematology analyzers and reagents market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis